Stockscreener 앱 받기
0.6935
1.55%
0.0435
Tela Bio Inc 주식(TELA)의 최신 뉴스
TELA Bio (TELA) CEO adds 12,500 shares in August buy - Stock Titan
TELA Bio (TELA) Q2 2026 Earnings Call Transcript - AOL.com
TELA (TELA) Quarter in Focus: The EPS Result Is Below Expectation under the Current Snapshot; Market Response: The Share Price Sheds 1.08% in the Available RecordProduct Revenue Analysis - vinanet.vn
TELA (TELA) Close and Levels: Ends Lower by 1.54% at $0.64 in the Latest Session; Chart Reference: the $0.61 to $0.67 Range Remains in Focus on the DayKAMA Signal - vinanet.vn
SILVERARC CAPITAL MANAGEMENT, LLC Trims TELA Bio Inc (TELA) Stak - GuruFocus
TELA Bio Pulls 2026 Outlook as Sales Fall, Loss Widens - MyChesCo
TELA Bio (TELA) CEO buys 15,000 shares at $0.6978 - Stock Titan
TELA Bio CEO Heather C. Getz acquires common shares worth $10,467 - Bitget
Tela Bio Earnings Call: Growth Meets Execution Risks - TipRanks
TELA Bio (TELA) stake: Nantahala group reports 12.94% ownership of 5.79M shares - Stock Titan
TELA BIO (TELA): SilverArc Capital and Devesh Gandhi disclose 2.14M-share 4.8% stake - Stock Titan
TELA Bio, Inc. (NASDAQ:TELA) Just Reported And Analysts Have Been Cutting Their Estimates - Moomoo
TELA Stock Price, Quote & Chart - ChartMill
TELA Bio (TELA) Drops 5.86% to $0.68 as Micro-Cap Med-Tech Stock Approaches Critical SupportOvernight Profile - vinanet.vn
Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report - simplywall.st
TELA Bio, Inc. Revenue Breakdown – BOATS:TELA - TradingView
TELA Bio, Inc. 2026: Revenue $19.29M, EPS ($0.2) — 10-Q Summary - TradingView
TELA Bio (NASDAQ: TELA) faces going concern doubt amid debt covenants and cash burn - Stock Titan
TELA Bio loss hits USD 9.3M in Q2 2026 - Medical Buyer
TELA BIO (TELA): SilverArc and Devesh Gandhi report 4.8% ownership stake - Stock Titan
TELA Bio, Inc. Stock 12‑Month Price Target Cut to $2.1, Implies 126% Upside - TradingView
TELA Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 12.4%One-Time Loss Impact - vinanet.vn
Tela Bio earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigati - GuruFocus
TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ... - Yahoo Finance
TELA Bio, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
TELA Looks 43.6% Undervalued on GF Value™ Despite Operational Un - GuruFocus
Transcript : TELA Bio, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com
TELA Bio misses Q2 revenue, withdraws full-year guidance - scanx.trade
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
TELA Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: TELA Bio misses Q2 2026 estimates, withdraws guidance - Investing.com
Is TELA Bio Inc (TELA) Positioned for Recovery After Q2 Earnings Miss? GF Score: 57/100 - GuruFocus
Q2 2026 TELA Bio Inc Earnings Call Transcript - GuruFocus
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook - TradingView
TELA Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
TELA Bio Reports Second Quarter 2026 Financial Results - The Manila Times
BRIEF-TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million - TradingView
TELA Bio Withdraws 2026 Revenue Guidance as Sales Fall 4% - Stock Titan
TELA Bio Names Getz CEO as Founder Koblish Steps Aside - MyChesCo
TELA Bio Inc (TELA) Stock Analysis & Forecast - TradingKey
TELA Bio Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
TELA Bio Inc (TELA) Stock News Today - TradingKey
TELA Bio Inc (TELA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
People on the Move: Heather Getz Joins TELA Bio as Chief Executive Officer - BioBuzz
Earnings To Watch: TELA Bio Inc (TELA) Q2 2026 -- GF Value Sees 97% Upside - Yahoo Finance
TELA Q2'26 Earnings: EPS estimate is (0.17) USD - TradingView
TELA Bio (TELA) Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Commercialization CostsEBITDA Analysis - vinanet.vn
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - marketscreener.com
Large equity grants for TELA Bio, Inc. (TELA) CEO Heather Getz - Stock Titan
TELA Bio, Inc. (TELA) CEO discloses 5,000-share ownership stake - Stock Titan
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio’s New CEO and 11 New Hires Get Stock Grants - Stock Titan
TELA Bio appoints Heather Getz as new CEO - The Globe and Mail
TELA Bio appoints Heather Getz as chief executive officer By Investing.com - Investing.com Australia
Earnings Preview: TELA Bio to Report Financial Results Post-market on August 10 - moomoo.com
TELA Bio appoints Heather Getz as chief executive officer - Investing.com
TELA Bio Appoints Heather Getz as Chief Executive Officer and Director - Quiver Quantitative
Heather Getz named CEO of TELA Bio as Antony Koblish exits - TradingView
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director - Yahoo Finance
TELA Q2'26 Earnings: revenue estimate is 20.01M USD - TradingView
TELA Bio Q1 2026 Earnings: EPS Misses Estimates, Stock Rises 2.83% as Focus Shifts to Operational ProgressShare Repurchase Impact - vinanet.vn
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference - The Manila Times
TELA|TELA Bio Inc|Price:0.644|Chg%:-0.034 - TradingKey
TELA Bio's Aug. 12 Conference Presentation Will Stream Live - Stock Titan
TELA Bio Sets Aug. 10 Earnings Call and Business Update - MyChesCo
0.78%
0.31%
자본화:
|
볼륨(24시간):